Therapeutic Human Polyclonals
Mountain View
About Therapeutic Human Polyclonals
THP is an emerging biotechnology company focused on research in the field of human antibody technologies. THP has developed a unique transgenic mammalian platform to create human antibodies. The technology will enable the generation of both monoclonal and polyclonal antibody therapeutics with enhanced efficacy.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Website: polyclonals.com
Canonical: https://fsome.com/organization/therapeutic-human-polyclonals-2022964 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.